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INTRODUCTION
Although the natural history of diabetic nephropathy for
patients with type 2 diabetes is not well delineated, five
stages characterize the progression of this disease. During
early stage type 2 diabetes, renal hyperperfusion and increas-
ed glomerular filtration develop and are followed by stages
of microalbuminuria that progress to overt nephropathy and
renal failure. Multiple biochemical mechanisms have been
proposed to explain the progression of diabetic nephropa-
thy, including hyperglycemia-induced increased polyol path-
way flux, increased accumulation of advanced glycation end
products, the activation of protein kinase C, and increased
hexosamine pathway flux (1). In addition to hyperglycemia-
induced biochemical factors, hemodynamic abnormalities
including systemic and glomerular hypertension play a crit-
ical role in the progression of diabetic nephropathy (2).
There is a hypothesis that salt-sensitive hypertension, in-
cluding hypertension in diabetic nephropathy, results from
abnormally enhanced tubuloglomerular feedback and im-
paired pressure natriuresis (3). One of the important mecha-
nisms underlying abnormal renal sodium handling involves
the altered expressions of sodium transporters in renal tubules
(4). Recently, a variety of specific antibodies have been pro-
duced against renal sodium transporter proteins (5-8). Thus,
it is now possible to follow changes in the expression of so-
dium transporters in response to systemic physiologic dis-
turbances by using immunoblotting and immunohistochem-
istry. Many investigators have described the altered expres-
sion of renal sodium transporters in streptozotocin-induced
diabetes mellitus rat models or animal models which have
diabetic nephropathy with early renal insufficiency (9-11).
In the present study, Otsuka Long-Evans Tokushima Fatty
(OLETF) rats were used as an animal model of type 2 dia-
betes mellitus, and Long-Evans Tokushima Otsuka (LETO)
rats were used as their diabetes-resistant counterparts. OLETF
rats developed from Long-Evans rats showed higher blood
glucose levels than the LETO control rats after 18 weeks of
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Altered Renal Sodium Transporter Expression in an Animal Model of
Type 2 Diabetes Mellitus
Hemodynamic factors play an important role in the development and/or progres-
sion of diabetic nephropathy. We hypothesized that renal sodium transporter dys-
regulation might contribute to the hemodynamic alterations in diabetic nephropa-
thy. Otsuka Long Evans Tokushima Fatty (OLETF) rats were used as an animal
model for type 2 diabetes. Long Evans Tokushima (LETO) rats were used as con-
trols. Renal sodium transporter regulation was investigated by semiquantitative
immunoblotting and immunohistochemistry of the kidneys of 40-week-old animals.
The mean serum glucose level in OLETF rats was increased to 235± ±25 mg/dL at
25 weeks, and the hyperglycemia continued up to the end of 40 weeks. Urine pro-
tein/creatinine ratios were 10 times higher in OLETF rats than in LETO rats. At 40th
week, the abundance of the epithelial sodium channel (ENaC)  -subunit was inc-
reased in OLETF rats, but the abundance of the ENaC  -subunit was decreased.
No significant differences were observed in the ENaC  -subunit or other major
sodium transporters. Immunohistochemistry for the ENaC  -subunit showed incre-
ased immunoreactivity in OLETF rats, whereas the ENaC  -subunit showed reduc-
ed immunoreactivity in these rats. In OLETF rats, ENaC  -subunit upregulation
and ENaC  -subunit downregulation after the development of diabetic nephropa-
thy may reflect an abnormal sodium balance.
Key Words : Diabetic Nephropathies; Rats, Inbred OLETF; Sodium-Hydrogen Exchanger 3; Bumetanide
Sensitive NaK2Cl Cotransporter; Thiazide Sensitive Nacl Cotransporter; Epithelial Sodium Channel
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age (12). Observed sequential histologic changes in OLETF
rats were glomerular enlargement and mesangial expansion
after 22 weeks of age, mesangial sclerosis and exudative le-
sions after 36 weeks of age, and total glomerular obsolescence
of almost 14% of glomeruli at 46 weeks of age (13). To study
long-term alteration of expression of renal sodium transporters
in the diabetic nephropathy of type 2 diabetes, studies were
performed in 40 week-old animals. We undertook this study
to determine how these sodium transporters are regulated dur-
ing the progression of diabetic nephropathy in type 2 diabetes.
MATERIALS AND METHODS
Animals 
Experiments were performed using male OLETF rats as
the diabetic group (n=6) and male LETO rats as the control
group (n=6). These animals were kindly donated by Otsuka
Pharmaceuticals (Tokushima, Japan). All animal procedures
were approved by the animal ethics review committee of
the Clinical Research Institute of Seoul National University
Hospital. Rats were housed individually and had free access
to standard rat chow and tap water. Physiologic data were
collected at 12, 25, 30, and 40 weeks of age, and animals were
sacrificed at 40 weeks of age. 
Physiologic measurement
Three days before physiologic data collection, rats were indi-
vidually placed in metabolic cages for adaptation. Body weights
were monitored. Systolic blood pressure (SBP) was measured
3 times at tail arteries, and average values were used (Non-
invasive Blood Pressure system; Harvard Apparatus, Hollis-
ton, MA, U.S.A.). Twenty-four hour urine was collected and
the amounts were measured. We analyzed urine electrolyte
and creatinine (Cr) levels using an ion-selective method (Sys-
tem E4A; Beckman Coulter Inc., Fullerton, CA, U.S.A.) and
urine protein concentrations by spectrophotometry (Hitachi
7170 Automatic Analyzer; Hitachi Medical Co., Tokyo, Japan).
Urine osmolality was measured using a cryoscopic osmome-
ter (Osmomat 030-D-M, Gonotec, Berlin, Germany).
At 40 weeks, rats were anesthetized with an intraperitoneal
(i.p.) injection of ethyl carbamate (Choohgwae Pharma Co.,
Seoul, Korea), and laparotomies were conducted. Blood was
collected from the aortas, and glucose, Cr, and Na levels were
measured (Hitachi 747 Autoanalyzer; Hitachi Medical Co.).
Glycosylated hemoglobin (HbA1c) was measured using a high
performance liquid chromatograph (Bio-Rad VARIANT
turbo-II hemoglobin testing system; Bio-Rad Laboratories
Inc., Hercules, CA, U.S.A.). Creatinine clearance (Ccr) and
fractional excretion of sodium (FENa) were calculated using
measured values.
Semiquantitative immunoblotting
We evaluated the abundances of major renal sodium trans-
porters from whole-kidney homogenates by immunoblotting.
After blood collection, right kidneys were rapidly removed.
Whole kidneys were homogenized in 10 mL of an ice-cold
isolation solution (250 mM sucrose, 10 mM triethanolamine,
1  g/mL leupeptin, and 1 mg/mL phenylmethylsulfonyl flu-
oride (pH 7.6) at 15,000 rpm with 3 strokes for 15 sec with
a tissue homogenizer (PowerGun 125; Fisher Scientific, Pitts-
burgh, PA, U.S.A.). After homogenization, total protein con-
centrations were measured by bicinchoninic acid protein assays
(BCA Reagent Kit; Sigma, St Louis, MO, U.S.A.) and adjust-
ed to reach the same protein concentration (2.5  g/ L) with
isolation solution. Samples were stabilized by adding 1 vol
of 5×Laemmli sample buffer to 4 vols sample and heating at
60℃ for 15 min. To confirm equal protein loading, ‘‘loading
gels’’ were made for each sample set to allow fine adjustment
of loading amounts. Five micrograms of protein from each sam-
ple were loaded into individual lanes and electrophoresed on
12% polyacrylamide-SDS minigels using a Mini-PROTEAN
II electrophoresis apparatus (Bio-Rad Laboratories Inc.) and
then stained with Coomassie blue dye. Three selected bands
from these gels were scanned (SLB Mylmager SL-6 Digital
Imaging System; UVP Inc., Upland, CA, U.S.A.) to deter-
mine the densities and the relative amounts of protein load-
ed per lane. Finally, protein concentrations were corrected to
reflect these measurements. The same amount of protein was
loaded in each lane of 8% or 10% polyacrylamide-SDS minigels
and electrophoresed. The proteins were then transferred elec-
trophoretically to nitrocellulose membranes (Bio-Rad Labo-
ratories Inc.). After blocking with 5% skim milk in PBS-T
(80 mM Ha2HPO4, 20 mM NaH2PO4, 100 mM NaCl, and
0.1% Tween-20, [pH7.5]) for 1 hr, the membranes were probed
overnight at 4℃ with primary antibodies and then incubat-
ed with secondary donkey anti-rabbit horseradish peroxidase
conjugated antibody (31458; Pierce, Rockford, IL, U.S.A.).
Sites of antigen-antibody reaction were viewed using enhanced
chemiluminescence substrate (LumiGLO Reserve Chemilu-
minesecnce Substrate Kit; KPL, Gaithersburg, MD, U.S.A.)
and exposure to radiography film (Hyperfilm; Amersham Phar-
macia Biotech, U.K.). To facilitate semiquantitative immuno-
blotting, we normalized the band densities by dividing by
mean values of corresponding control group values; calculat-
ed values were expressed as percentages.
Immunohistochemistry
Each left kidney was perfused by retrograde perfusion via
the abdominal aorta by inserting a perfusion needle into the
abdominal aorta and dissecting the inferior vena cava to es-
tablish an outlet. Blood was washed from the kidneys using
cold 1% phosphate-buffered saline (PBS). After completing
this perfusion, the kidneys were removed, sliced into 5-mm-1036 Y.K. Oh, K.W. Joo, J.W. Lee, et al.
thick pieces, and immersed in 4% paraformaldehyde solu-
tion (P6148 in PBS, pH 7.4; Sigma) overnight at 4℃. After
embedding in paraffin, kidneys were sectioned at 5  m thick-
ness using a microtome (RM 2145; Leica Instruments, Nus-
sloch, Germany). 
Paraffin sections were then de-paraffinized with 100% xy-
lene and rehydrated with graded ethanol. To retrieve anti-
gens, sections were boiled in a preheated target retrieval solu-
tion (0.01 M, pH 6.0, S2031; DakoCytomation, Carpinte-
ria, CA, U.S.A.) 3 times for 10 min using a microwave. Sec-
tions were then treated with Dual Endogenous Enzyme Block
(K4065; DakoCytomation) for 10 min to eliminate endoge-
nous peroxidase activity, washed with distilled water and PBS,
incubated overnight at 4℃ with primary antibodies dilut-
ed in PBS, and washed with buffer solution. Labeled Poly-
mer-HRP (DakoCytomation) was then applied to the sections,
and they were then incubated for 40 min at room tempera-
ture. After the slides were rinsed with substrate buffer, 3,3’-
diaminobenzidine (DAB) chromogen solution (DakoCytoma-
tion) was applied, and the slides were incubated for 10 min.
This reaction was stopped with distilled water. Sections were
counterstained with hematoxylin, and the slides were washed
with tap water, dehydrated, and mounted.
Primary antibodies
In the present study, we used previously characterized poly-
clonal antibodies, namely, affinity-purified polyclonal antibo-
dies against sodium hydrogen exchanger 3 (NHE3) (5), bu-
metanide sensitive NaK2Cl co-transporter (NKCC2) (6), thi-
azide-sensitive NaCl co-transporter (NCC) (7), and the  -,  -,
and  -subunits of the epithelial sodium channel (ENaC) (8). 
Statistics
Values were presented as means±standard errors. Quanti-
tative comparisons between groups were determined using
the Mann-Whitney U-test. Statistical analyses were conduct-
ed using SPSS software (SPSS Inc., Chicago, IL, U.S.A.), and
pvalues of <0.05 were considered statistically significant.
RESULTS
Physiologic parameters
The mean serum glucose level of OLETF rats was elevated
to 235±25 mg/dL at 25 weeks and hyperglycemia contin-
ued to 40 weeks of age (30th week: 260±42 mg/dL, 40th
week: 275±30 mg/dL, Fig. 1A). However, LETO rats did
not develop hyperglycemia (25th week: 126±10 mg/dL,
30th week: 122±14 mg/dL, 40th week: 140±9 mg/dL,
Fig. 1A). The HbA1c values of OLETF rats were also higher
than those of LETO rats at 40 weeks of age (LETO vs. OLETF:
3.7±0.0 vs. 6.3±0.2%, p<0.05, Table 1). Body weights
of OLETF rats were greater than those of LETO rats between
12 and 30 weeks of age (12th week: 322±5 vs. 393±6 g,
p<0.05; 25th week: 435±13 vs. 547±23 g, p<0.05; 30th
week: 522±17 vs. 647±6 g, p<0.05, Fig. 1B), but were
not different at 40 weeks of age (557±20 vs. 509±25 g,
Fig. 1B). SBP values of OLETF rats were higher than those
of LETO rats at 25 and 30 weeks of age (25th week: 138±
6 vs. 175±6 mmHg, p<0.05; 30th week: 152±4 vs. 193
±4 mmHg, p<0.05, Fig. 1C), but were not significantly
different at 40 weeks of age (127±2 vs. 140±5 mmHg,
Fig. 1C). As diabetic nephropathy progressed, urine volumes
and protein excretion also increased. Twenty-four hour urine
volumes per kg of body weight increased after 25 weeks of age
in OLETF rats, and this difference between the 2 groups in-
creased progressively until 40 weeks of age (40th week: 15±
3 vs. 106±33 mL/day/kg, p<0.05, Fig. 1D). The mean urine
protein/Cr ratio of OLETF rats was 10 times higher than that
of LETO rats at 40 weeks of age (1.0±0.1 vs. 11.8±2.5
mg/mg, p<0.05, Table 1). However, serum Cr levels were
lower in OLETF rats (0.75±0.02 vs. 0.65±0.02 mg/dL,
p<0.05, Table 1) and Ccr levels were higher at 40 weeks of
age (1.6±0.2 vs. 3.3±0.2 mL/min/kg Bwt, p<0.05, Table
1). FENa values of OLETF rats showed a tendency to be lower
than those of LETO rats at 30 and 40 weeks of age; however,
the difference was not statistically significant (Fig. 1E). The
amounts of daily excretion of sodium tended to be insignifi-
cantly higher than those of LETO rats at 30 and 40 weeks
of age (Fig. 1F, Table 1).
Immunoblotting
The abundance of NHE3 at 40 weeks of age was not dif-
ferent between the two groups (LETO vs. OLETF: 100±8
vs. 103±17%, Fig. 2A). The abundances of NKCC2 (100
±27 vs. 108±18%, Fig. 2B) and NCC (100±8 vs. 77±
8%, Fig. 2C) were not significantly altered according to the
progression of diabetic nephropathy. However, the subunits
of ENaC showed heterogeneous responses to the disease pro-
gression. The abundance of the ENaC  -subunit was not
significantly different between the two groups at 40 weeks
of age (100±37 vs. 49±5%, Fig. 3A). However, the abun-
dance of the ENaC  -subunit was significantly increased
(100±13 vs. 171±20%, Fig. 3B) in OLETF rats, and the
abundance of the ENaC  -subunit was significantly reduced
(100±18 vs. 32±9%, Fig. 3C) in OLETF rats at 40 weeks
of age.
Immunohistochemistry
Compatible with immunoblotting results, the ENaC  -
subunit showed markedly increased immunoreactivity in
the renal cortex of OLETF rats compared with those of LETO
rats at 40 weeks of age (Fig. 4A, B), whereas the ENaC  -Renal Sodium Transporters in Animal Model of Type 2 DM 1037
subunit showed reduced immunoreactivity in the renal cor-
tex in these rats at this time (Fig. 4C, D). 
DISCUSSION
Blood glucose levels in OLETF rats increased beyond the
diagnostic criteria of diabetes at 25 weeks of age, and hyper-
glycemia continued to study termination at 40 weeks of age.
In addition, the mean HbA1c level in OLETF rats was higher
than that in LETO rats at 40 weeks of age. These findings
are consistent with previous reports that OLETF rats show
elevated glucose levels at 18 weeks of age (12). After the de-
velopment of hyperglycemia, SBP values were elevated in
OLETF rats. Moreover, 24-hr urine volumes, urine protein/
Cr ratios, and Ccr levels were higher in OLETF rats than in
LETO rats at 40 weeks of age. Although the differences were
not statistically significant, the amounts of daily excretion
of sodium tended to be higher than those of LETO rats at 30
and 40 weeks of age. The findings resulted from increased
urine volumes of OLETF rats. Indeed, FENa values of OL-
ETF rats showed a tendency to be lower than those of LETO
rats at 30 and 40 weeks of age. According to our physiologic
data and a previous report about histologic changes in OLE-
Fig. 1. Serial changes in plasma glucose (A), body weight (B), systolic blood pressure measured using a tail cuff (C), 24-hr urine volume
per kg body weight (D), fractional excretion of sodium (E), and daily urine sodium excretion (F) in LETO and OLETF rats at 12, 25, 30, and
40 weeks of age. Symbols are     , OLETF;     , LETO. *p<0.05.
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TF rats (13), the stage of diabetic nephropathy at 40 weeks
of age in this model reflected overt nephropathy before the
development of renal failure.
In the present study, we analyzed changes in the abundance
of the major sodium transporters in renal tubule, as these
may be responsible for hemodynamic changes that occurred
in-line with the progression of diabetic nephropathy. Our
results show that the sodium transporters expressed in the
proximal tubule, the thick ascending limb of loop of Henle,
and the distal convoluted tubule were not different in age-
matched OLETF and LETO rats. However, ENaC subunit
expression in the second part of the distal convoluted tubule,
connecting tubule, and collecting duct showed heteroge-
neous changes in OLETF rats. 
In diabetic obese Zucker rats, another type 2 diabetic ani-
mal model, the abundances of NHE3 in the cortex and outer
medulla and of NKCC2 in the outer medulla were lower
than in those of nondiabetic lean Zucker rats at 6 months of
age (11). However, in the present study, the abundances of
NHE3 and NKCC2 in OLETF and LETO rats were similar
at 40 weeks of age. We believe that these differences are due
to different stages of diabetic nephropathy in the two ani-
mal models. In the present study, the mean Ccr per kg of
body weight for OLETF rats was higher than in LETO rats.
However, in diabetic obese Zucker rats, Ccr per kg of body
weight was lower than in lean Zucker rats. Therefore, the
reduced abundances of NHE3 and NKCC2 of diabetic obese
Zucker rats probably reflected glomerulotubular balance
because GFR was beginning to fall at this time. In an early
study of younger Zucker rats, which showed insulin resis-
tance but which were not diabetic, no differences were found
between lean and obese rats with respect to the abundances
of NHE3 and NKCC2 (14). These findings suggest that the
proximal tubule and thick ascending limb transporter ex-
pressions are not changed during early diabetic nephropathy
before renal function deteriorates.
The distal portion of the renal tubule, including the dis-
tal convoluted tubule and the collecting duct, plays an im-
portant role in the fine tuning of sodium reabsorption. NCC
in the distal convoluted tubule is under the control of aldos-
Values are mean±SE.
LETO, Long-Evans Tokushima Otsuka rat; OLETF, Otsuka Long-Evans
Tokushima Fatty rat; HbA1c, glycosylated hemoglobin; Bwt, body weight;
Cr, creatinine; Ccr, creatinine clearance.
*p<0.05.
LETO (n=6) OLETF (n=6)
Kidney weight (g/kg Bwt) 2.6±0.1 4.0±0.3*
HbA1c (%) 3.7±0.0 6.3±0.2*
Serum Na (mM/dL) 142.5±0.7 140.5±4.5
Serum Cr (mg/dL) 0.75±0.02 0.65±0.02*
Urine protein/Cr (mg/mg) 1.0±0.1 11.8±2.5*
Ccr (mL/min/kg Bwt) 1.6±0.2 3.3±0.2*
Urine osmolality (Osm/kg H2O) 2.99±0.21 1.03±0.26*
Urine osmoles (Osm/day/kg Bwt) 42.2±5.6 82.0±20.9
Table 1. Physiologic data of LETO and OLETF rats at 40 weeks
of age
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Fig. 3. Immunoblots (A-C) and immunoblot data summaries (D)
for ENaC subunits. Representative blots are from 40 week-old
LETO and OLETF rats. Each lane was loaded with whole kidney
homogenate from a different rat. Equal amounts of protein were
loaded in all lanes. Immunoblots were probed with (A) anti-ENaC
-subunit (3560-2-4), (B) anti-ENaC  -subunit (3755-2), and (C)
anti-ENaC  -subunit (A881) antibodies. Band densities of the
ENaC  -subunit were significantly increased, and band densities
for the ENaC  -subunit were significantly decreased in OLETF
rats vs. LETO rats. The relative abundances of ENaC  -subunit
were not affected by rat type. *p<0.05 
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terone, which up-regulates NCC expression (7). However,
in the present study, the abundance of NCC was not changed
in OLETF vs. LETO rats. This indicates that NCC expres-
sion in OLETF rats is not only modulated by aldosterone but
also influenced by other factors. 
In the present study, GFR was increased in OLETF rats vs.
LETO rats, which might have increased the distal delivery
of tubular fluid. Abdallah et al. reported that increased sodi-
um delivery to the distal tubule by high dose furosemide
infusion increased NCC protein abundance (15). However,
the abundance of NCC was not changed by a low dose furose-
mide infusion (16). These findings suggest that the amount
of tubular fluid delivered to the distal tubule influences the
expression of NCC. In addition to aldosterone and the distal
delivery of tubular fluid, other mechanisms related to dia-
betic nephropathy progression also regulate the abundance
of NCC. In younger Zucker rats, the abundance of NCC was
increased in obese rats (14). However, consistent with the
findings in our OLETF rats, this increased expression of NCC
was not found in older diabetic Zucker rats (11). Song et al.
also recently reported that chronic insulin infusion and drink-
ing of glucose did not change the abundance of NCC (17).
Therefore, It is difficult to understand that NCC expression
is related with the progression diabetic nephropathy. 
The ENaC is a protein that is required for the reabsorption
of sodium in the connection tubule through the collecting
duct. ENaC is tetramer and is composed of  ,  , and  -sub-
units (18). Moreover, the physiologic activity and the abun-
dance of each subunit of ENaC is under the control of aldo-
sterone. Masilamani et al. reported that dietary NaCl restric-
tion and aldosterone infusion markedly increase the abun-
dance of the ENaC  -subunit in rat kidneys without increas-
ing those of  - and  -subunits (8). In their study, aldosterone
was found to induce a shift in the molecular weight of the
ENaC  -subunit from 85 kDa to 70 kDa. However, in the
present study, the abundance of the ENaC  -subunit was not
different in OLETF and LETO rats, despite an increase in the
abundance of the ENaC  -subunit and a decrease in that of
the ENaC  -subunit. The results of our study demonstrate
that changes in the abundance of ENaC subunits are not con-
sistent with the effect of aldosterone on ENaC expression.
Although the regulation of ENaC is primarily under the
control of aldosterone, other hormones, such as insulin (19)
and vasopressin (20), may also play a role in this process. In
Fig. 4. Immunohistochemistry of ENaC  and  -subunits in the cortex of LETO and OLETF rats. The ENaC  -subunit showed enhanced
immunostaining (A, B) and the ENaC  -subunit diminished immunostaining (C, D) in 40 week-old OLETF rats vs. LETO rats (×100). 
B A
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addition to regulation by many hormones, changes in the
abundance of ENaC subunits were non-coordinated to the
same stimulation (8).
The up-regulation of the ENaC  -subunit abundance also
was observed in younger and non-diabetic obese Zucker rats
of 2 and 4 months of age, respectively (14), and the absolute
abundance of the ENaC  -subunit was significantly increas-
ed in diabetic Zucker rats after correcting for the renal hyper-
trophy (11). Therefore, an increase in the abundance of the
ENaC  -subunit is probably not a result of hyperinsuline-
mia or hyperglycemia, but rather may be related to either
hypertension or insulin resistance. The mechanism of reduc-
ed ENaC  -subunit abundance needs to be investigated in
the future. Different methods of regulation of these ENaC
subunits appear to be related to many other factors that are
associated with the development and progression of diabetic
nephropathy. The physiologic meaning of these different
methods should be elucidated.
Hypertension is one of the most important risk factors for
the progression of diabetic nephropathy (21). An increase in
sodium and water retention is required for the development
of most forms of hypertension. However, pressure natriure-
sis, which protects the kidneys from sodium retention and
hypertension, may not be fully functional in salt sensitive-
hypertensive states, such as diabetic nephropathy. One of
the mechanisms whereby the kidney regulates sodium reab-
sorption is via altered expression of renal tubular sodium
transporters, especially ENaC (4, 22). Because of the lack of
a downstream sodium transport system beyond ENaC, so-
dium reabsorption by ENaC in the collecting duct becomes
the final renal adjustment of sodium balance. The results of
many studies indicate that an increase in sodium transport
by ENaC may be a common and important component of
salt-sensitive hypertension (23, 24). Therefore, the altered
expression of ENaC subunits in OLETF rats may be an im-
portant mechanism of abnormal salt handling and hyper-
tension which are largely responsible for the progression of
diabetic nephropathy.
In conclusion, the abundance of the ENaC  -subunit was
founded to be increased and that of ENaC  -subunit to be
decreased in overt proteinuric stage diabetic nephropathy in
the present murine type 2 diabetic model. We suggest that
these changes are related to an altered sodium balance, which
might be associated with hemodynamic changes, and that this
is responsible for the progression of diabetic nephropathy.
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